Cargando…
An indirect comparison of HbA(1c) treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method
No head-to-head comparisons exist between once-weekly (QW) glucagon-like peptide-1 receptor agonists; accordingly, this indirect comparison was conducted to evaluate the comparative efficacy of QW albiglutide vs QW exenatide. Following a systematic literature search, it was determined that HARMONY 7...
Autores principales: | Martin, Alan A, Parks, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876841/ https://www.ncbi.nlm.nih.gov/pubmed/27274297 http://dx.doi.org/10.2147/DMSO.S100775 |
Ejemplares similares
-
Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
por: Vetter, Marion L., et al.
Publicado: (2019) -
Bücher
Publicado: (2021) -
The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France
por: Basson, Mickael, et al.
Publicado: (2017) -
A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab
por: Du Jardin, Kristian Garn, et al.
Publicado: (2020) -
Bücher in fünf Minuten
Publicado: (2009)